VERONICA CANNON: Open Payments
NPI 1689080384 · MALVERN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 8 payments from 4 companies in 2025. Trend: 2023 $94 · 2024 $88 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Lilly USA, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, CAPLYTA, MOUNJARO, Qelbree.
Industry payments across AR — which companies pay providers there.
